Phillip Frost - Opko Health Chairman of the Board, CEO
| OPK Stock | 596.00 40.40 7.27% |
Chairman
Dr. Phillip Frost serves as Chairman of the Board and Chief Executive Officer at Opko health, Inc. Dr. Frost was the Chief Executive Officer of the Company and Chairman of the Board since March 2007. Dr. Frost serves as a director for Castle Brands, a developer and marketer of premium brand spirits, and Cocrystal Pharma, Inc., a publicly traded biotechnology company developing new treatments for viral diseases. He serves as a member of the Board of Trustees of the University of Miami, the Skolkovo Foundation Scientific Advisory Council in Russia, the Shanghai Institute for Advanced Immunochemical Studies in China, and The Florida Council of 100 and as a Trustee of each of the Miami Jewish Home for the Aged and the Mount Sinai Medical Center. He serves as Chairman of Temple EmanuEl, Governor of Tel Aviv University and is a member of the Executive Committee of The Phillip and Patricia Frost Museum of Science. Dr. Frost served as a director of Ladenburg Thalmann Financial Services Inc., an investment banking, asset management, and securities brokerage firm providing services through its principal operating subsidiary, Ladenburg Thalmann Co. Inc., from 2004 to 2018 and had served as its Chairman from July 2006 until September 2018, a director of Teva Pharmaceutical Industries, Limited, or Teva from January 2006 until February 2015 and had served as Chairman of the Board of Teva from March 2010 until December 2014. Dr. Frost previously served as Vice Chairman of Cogint, Inc., now known as Fluent, Inc., and as a director for Sevion Therapeutics, Inc. prior to its merger with Eloxx Pharmaceuticals, Inc., and TransEnterix, Inc., . Dr. Frost had served as Chairman of the Board of Directors and Chief Executive Officer of IVAX Corporation from 1987 until its acquisition by Teva in January 2006. Dr. Frost was Chairman of the Board of Directors of Key Pharmaceuticals, Inc. since 2007.
| Age | 87 |
| Tenure | 17 years |
| Phone | 305 575 4100 |
| Web | https://www.opko.com |
Phillip Frost Latest Insider Activity
Tracking and analyzing the buying and selling activities of Phillip Frost against Opko Health stock is an integral part of due diligence when investing in Opko Health. Phillip Frost insider activity provides valuable insight into whether Opko Health is net buyers or sellers over its current business cycle. Note, Opko Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Opko Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Phillip Frost 3 days ago Acquisition by Phillip Frost of 125000 shares of Opko Health at 1.595 subject to Rule 16b-3 | ||
Phillip Frost over two weeks ago Acquisition by Phillip Frost of 199072 shares of Opko Health at 1.534 subject to Rule 16b-3 | ||
Phillip Frost over three weeks ago Acquisition by Phillip Frost of 100000 shares of Opko Health at 1.59 subject to Rule 16b-3 | ||
Phillip Frost over a month ago Acquisition by Phillip Frost of 14800 shares of Opko Health at 1.78 subject to Rule 16b-3 |
Opko Health Management Efficiency
The company has return on total asset (ROA) of (0.0659) % which means that it has lost $0.0659 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.1867) %, meaning that it generated substantial loss on money invested by shareholders. Opko Health's management efficiency ratios could be used to measure how well Opko Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 9 records | CHAIRMAN Age | ||
| Leon Recanati | Kamada | 71 | |
| David Tsur | Kamada | 73 | |
| Amir Elstein | Tower Semiconductor | 63 | |
| Russell Ellwanger | Tower Semiconductor | 68 | |
| Amir Elstein | Teva Pharmaceutical Industries | 63 | |
| Sol Barer | Teva Pharmaceutical Industries | 71 | |
| Michael Federmann | Elbit Systems | 75 | |
| David Kostman | Nice | 55 | |
| David Federmann | Elbit Systems | 44 | |
Management Performance
| Return On Equity | -0.19 | |||
| Return On Asset | -0.0659 |
Opko Health Leadership Team
Elected by the shareholders, the Opko Health's board of directors comprises two types of representatives: Opko Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Opko. The board's role is to monitor Opko Health's management team and ensure that shareholders' interests are well served. Opko Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Opko Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Arie Gutman, Pres API | ||
| James DeMarco, VP Sales | ||
| Adam Logal, CFO, Chief Accounting Officer, Sr. VP and Treasurer | ||
| Phillip Frost, Chairman of the Board, CEO | ||
| Akhtar Ashfaq, Senior Vice President - Clinical Research and Development of OPKO Health's Renal Division | ||
| Elias MD, Pres Chairman | ||
| JD Esq, Chief Laboratories | ||
| MBA MBA, Vice Officer | ||
| Jon MD, Advisor |
Opko Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Opko Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.19 | |||
| Return On Asset | -0.0659 | |||
| Profit Margin | (0.26) % | |||
| Operating Margin | (0.20) % | |||
| Current Valuation | 3.9 B | |||
| Shares Outstanding | 772.69 M | |||
| Shares Owned By Insiders | 45.87 % | |||
| Shares Owned By Institutions | 24.36 % | |||
| Price To Book | 0.63 X | |||
| Price To Sales | 2.78 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Opko Stock
When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Opko Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Opko Stock refer to our How to Trade Opko Stock guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.